A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: Prevention by a histone deacetylase inhibitor

Cell Biology International

Volumn 33, Issue 8, 2009, Pages 899-903

  Abujamra, Ana Lucia ^a   Almeida, Viviane R ^a   Brunetto, Algemir L ^a   Schwartsmann, Gilberto ^a,b   Roesler, Rafael ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Epigenetic mechanisms; Gastrin releasing peptide receptor; Histone deacetylase inhibitors; Neuroblastoma; RC 3095; Sodium butyrate

Indexed keywords

BUTYRIC ACID; GASTRIN RELEASING PEPTIDE RECEPTOR; GASTRIN RELEASING PEPTIDE RECEPTOR ANTAGONIST; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; RC 3095; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; EPIGENETICS; IN VITRO STUDY; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BOMBESIN; BUTYRATES; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASES; HUMANS; MICE; NEUROBLASTOMA; PEPTIDE FRAGMENTS; RECEPTORS, BOMBESIN; TUMOR CELLS, CULTURED;

MURINAE;

EID: 68149162732     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.04.014     Document Type: Article

References (22)

1. Castel V., Grau E., Noguera R., and Martínez F. Molecular biology of neuroblastoma. Clin Transl Oncol 9 (2007) 478-483
2. Casanueva F.F., Perez F.R., Casabiell X., Camina J.P., Cai R.Z., and Schally A.V. Correlation between the effects of bombesin antagonists on cell proliferation and intracellular calcium concentration in Swiss 3T3 and HT-29 cell lines. Proc Natl Acad Sci U S A 93 (1996) 1406-1411
3. Cornelio D.B., Roesler R., and Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol 18 (2007) 1457-1466
4. Dantas A.S., Luft T., Henriques J.A., Schwartsmann G., and Roesler R. Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: possible involvement of the GABAergic system. Peptides 27 (2006) 2307-2312
5. De los Santos M., Zambrano A., and Aranda A. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. Mol Cancer Ther 6 (2007) 1425-1432
6. dos Santos M.P., Schwartsmann G., Roesler R., Brunetto A.L., and Abujamra A.L. Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells. Leuk Res 33 (2009) 218-221
7. Flores D.G., Farias C.B., Leites J., Oliveira M.S., Lima R.C., Tamajusuku A.S., et al. Gastrin-releasing peptide receptors regulate proliferation of C6 glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism. Curr Neurovasc Res 5 (2008) 99-105
8. Ishola T.A., Kang J., Qiao J., Evers B.M., and Chung D.H. Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells. Biochim Biophys Acta 1770 (2007) 927-932
9. Kang J., Ishola T.A., Baregamian N., Morout J.N., Rychahou P.G., Evers B.M., et al. Bombesin induces angiogenesis and neuroblastoma growth. Cancer Lett 253 (2007) 273-281
10. Kim S., Hu W., Kelly D.R., Hellmich M.R., Evers B.M., and Chung D.H. Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann Surg 235 (2002) 621-629
11. Maris J.M., Hogarty M.D., Bagatell R., and Cohn S.L. Neuroblastoma. Lancet 369 (2007) 2106-2120
12. Moody T.W., Nakagawa T., Kang Y., Jakowlew S., Chan D., and Jensen R.T. Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation. J Mol Neurosci 28 (2006) 231-238
13. Pan L., Lu J., Wang X., Han L., Zhang Y., Han S., et al. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. Cancer 109 (2007) 1676-1688
14. Park J.R., Eggert A., and Caron H. Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 55 (2008) 97-120
15. Patel O., Shulkes A., and Baldwin G.S. Gastrin-releasing peptide and cancer. Biochim Biophys Acta 1766 (2006) 23-41
16. Pinski J., Schally A.V., Halmos G., Szepeshazi K., and Groot K. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res 54 (1994) 5895-5901
17. Qiao J., Kang J., Ishola T.A., Rychahou P.G., Evers B.M., and Chung D.H. Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma. Proc Natl Acad Sci U S A 105 (2008) 12891-12896
18. Qiao J., Kang J., Ko T.C., Evers B.M., and Chung D.H. Inhibition of transforming growth factor-beta/Smad signaling by phosphatidylinositol 3-kinase pathway. Cancer Lett 242 (2006) 207-214
19. Radulovic S., Cai R.Z., Serfozo P., Groot K., Redding T.W., Pinski J., et al. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi. Int J Pept Protein Res 38 (1991) 593-600
20. Sartelet H., Oligny L.L., and Vassal G. AKT pathway in neuroblastoma and its therapeutic implication. Expert Rev Anticancer Ther 8 (2008) 757-769
21. Schally A.V., Comaru-Schally A.M., Nagy A., Kovacs M., Szepeshazi K., Plonowski A., et al. Hypothalamic hormones and cancer. Front Neuroendocrinol 22 (2001) 248-291
22. Tonini G.P., and Pistoia V. Molecularly guided therapy of neuroblastoma: a review of different approaches. Curr Pharm Des 12 (2006) 2303-2317